Allurion Technologies (ALUR) Shares Outstanding (Weighted Average) (2022 - 2026)
Allurion Technologies posted quarterly Shares Outstanding (Weighted Average) of $13.4 million for Q1 2026, up 179.39% year-on-year from $4.8 million in Q1 2025, and up 76.96% on a QoQ basis from $7.5 million in Q4 2025.
Allurion Technologies (ALUR) has 5 years of Shares Outstanding (Weighted Average) data on file, last reported at $13.4 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 179.39% year-over-year to $13.4 million; the trailing twelve-month figure through Mar 2026 stood at $13.4 million (up 179.39% YoY), and the FY2025 full-year result was $7.5 million, up 235.74% from the prior year.
- Shares Outstanding (Weighted Average) for Q1 2026 stood at $13.4 million, up from $7.5 million in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $26.9 million in Q3 2022 and bottomed at $1.1 million in Q4 2022.
- The 5-year median for Shares Outstanding (Weighted Average) is $2.2 million (2024), against an average of $5.5 million.
- The widest annual swing landed in 2023, when Shares Outstanding (Weighted Average) plunged 95.31%; it then surged 281.32% in 2025.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $1.1 million in 2022, then surged by 32.18% to $1.4 million in 2023, then jumped by 57.89% to $2.2 million in 2024, then soared by 235.74% to $7.5 million in 2025, then surged by 76.96% to $13.4 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $13.4 million (Q1 2026), $7.5 million (Q4 2025), and $6.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Allurion Technologies | - | - | 1.23 Mn | 13.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.35 Mn |
| Dec 31, 2025 | 7.54 Mn |
| Sep 30, 2025 | 6.62 Mn |
| Jun 30, 2025 | 6.05 Mn |
| Mar 31, 2025 | 4.78 Mn |
| Dec 31, 2024 | 2.25 Mn |
| Sep 30, 2024 | 2.56 Mn |
| Jun 30, 2024 | 1.91 Mn |
| Mar 31, 2024 | 1.91 Mn |
| Dec 31, 2023 | 1.42 Mn |
| Sep 30, 2023 | 1.61 Mn |
| Jun 30, 2023 | 1.08 Mn |
| Mar 31, 2023 | 1.08 Mn |
| Dec 31, 2022 | 1.08 Mn |
| Sep 30, 2022 | 26.89 Mn |
| Jun 30, 2022 | 7.44 Mn |